Access the full text.
Sign up today, get DeepDyve free for 14 days.
M. Kudo, M. Kitano, T. Sakurai, N. Nishida (2015)
General Rules for the Clinical and Pathological Study of Primary Liver Cancer, Nationwide Follow-Up Survey and Clinical Practice Guidelines: The Outstanding Achievements of the Liver Cancer Study Group of JapanDigestive Diseases, 33
H. Sakaguchi, H. Uchida, M. Maeda, N. Matsuo, K. Kichikawa, H. Ohishi, H. Nishida, K. Ueno, K. Nishimine, J. Rösch*, Q. Guo (2008)
Combined transjugular intrahepatic portosystemic shunt and segmentai lipiodol hepatic artery embolization for the treatment of esophagogastric varices and hepatocellular carcinoma in patients with cirrhosis: Preliminary reportCardioVascular and Interventional Radiology, 18
F. Faitot, M. Allard, G. Pittau, O. Ciacio, R. Adam, D. Castaing, A. Cunha, G. Pelletier, D. Cherqui, D. Samuel, E. Vibert (2015)
Impact of clinically evident portal hypertension on the course of hepatocellular carcinoma in patients listed for liver transplantationHepatology, 62
D. Ganger, J. Klapman, V. McDonald, T. Matalon, S. Kaur, H. Rosenblate, Richard Kane, M. Saker, D. Jensen (1999)
Transjugular intrahepatic portosystemic shunt (TIPS) for Budd-Chiari syndrome or portal vein thrombosis: review of indications and problems.The American journal of gastroenterology, 94 3
R. Parker (2014)
Role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension.Clinics in liver disease, 18 2
J. García‐Pagán, K. Caca, C. Bureau, W. Laleman, B. Appenrodt, A. Luca, J. Abraldes, F. Nevens, J. Vinel, J. Mössner, J. Bosch (2010)
Early use of TIPS in patients with cirrhosis and variceal bleeding.The New England journal of medicine, 362 25
A. Parvinian, R. Gaba (2013)
Parallel TIPS for Treatment of Refractory Ascites and Hepatic HydrothoraxDigestive Diseases and Sciences, 58
A. Luca, R. Miraglia, S. Caruso, M. Milazzo, Cristina Sapere, L. Maruzzelli, G. Vizzini, F. Tuzzolino, B. Gridelli, J. Bosch (2011)
Short- and long-term effects of the transjugular intrahepatic portosystemic shunt on portal vein thrombosis in patients with cirrhosisGut, 60
D. Takizawa, S. Kakizaki, N. Sohara, Ken Sato, H. Takagi, H. Arai, K. Katakai, A. Kojima, Yutaka Matsuzaki, M. Mori (2007)
Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: Clinical Characteristics, Prognosis, and Patient Survival AnalysisDigestive Diseases and Sciences, 52
Bin Qiu, Mengfei Zhao, Z. Yue, Hongwei Zhao, Lei Wang, Z. Fan, F. He, Shan Dai, Jiannan Yao, Fuquan Liu (2015)
Combined transjugular intrahepatic portosystemic shunt and other interventions for hepatocellular carcinoma with portal hypertension.World journal of gastroenterology, 21 43
S Asahara, T Ikari, A Kamei (2004)
A case of diffuse type of hepatocellular carcinoma with tumor thrombosis of inferior vena cava (Vv3) and main trunk of portal vein (Vp4), showing marked response to transcatheter arterial chemoembolization with degradable starch microspheres (DSM-TACE)Nihon Shokakibyo Gakkai Zasshi, 101
D. Bettinger, E. Knüppel, W. Euringer, H. Spangenberg, M. Rössle, R. Thimme, Michael Schultheiss (2015)
Efficacy and safety of transjugular intrahepatic portosystemic shunt (TIPSS) in 40 patients with hepatocellular carcinomaAlimentary Pharmacology & Therapeutics, 41
G. Han, X. Qi, Chuang-ye He, Z. Yin, Jian-hong Wang, J. Xia, Zhiping Yang, M. Bai, Xiangjie Meng, J. Niu, Kaichun Wu, D. Fan (2011)
Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with symptomatic portal hypertension in liver cirrhosis.Journal of hepatology, 54 1
F. Salerno, C. Cammà, M. Enea, M. Rössle, F. Wong (2007)
Transjugular intrahepatic portosystemic shunt for refractory ascites: a meta-analysis of individual patient data.Gastroenterology, 133 3
Yuo-chen Kuo, M. Kohi, D. Naeger, R. Tong, K. Kolli, Andrew Taylor, J. Laberge, R. Kerlan, N. Fidelman (2013)
Efficacy of TACE in TIPS Patients: Comparison of Treatment Response to Chemoembolization for Hepatocellular Carcinoma in Patients With and Without a Transjugular Intrahepatic Portosystemic ShuntCardioVascular and Interventional Radiology, 36
K. Goh, Hamizah Razlan, J. Hartono, C. Qua, B. Yoong, P. Koh, B. Abdullah (2015)
Liver cancer in Malaysia: Epidemiology and clinical presentation in a multiracial Asian populationJournal of Digestive Diseases, 16
K. Moore, F. Wong, P. Ginés, M. Bernardi, A. Ochs, F. Salerno, P. Angeli, M. Porayko, R. Moreau, G. Garcia-Tsao, W. Jiménez, R. Planas, V. Arroyo (2003)
The management of ascites in cirrhosis: Report on the consensus conference of the international Ascites clubHepatology, 38
R. Gaba, A. Parvinian, L. Casadaban, P. Couture, S. Zivin, J. Lakhoo, J. Minocha, C. Ray, M. Knuttinen, J. Bui (2015)
Survival benefit of TIPS versus serial paracentesis in patients with refractory ascites: a single institution case-control propensity score analysis.Clinical radiology, 70 5
Shingo Asahara, Takaaki Ikari, A. Kamei, Eiichi Sato, Koichi Takano, N. Fujita, Miyuki Shimizu, Rikiya Fujita (2004)
Degradable starch microspheres (DSM) 併用肝動脈化学塞栓療法 (DSM-TACE) が著効した, 下大静脈および門脈腫瘍塞栓をともなうびまん型肝細胞癌の1例The Japanese journal of gastro-enterology, 101
L. Colombato (2007)
The Role of Transjugular Intrahepatic Portosystemic Shunt (TIPS) in the Management of Portal HypertensionJournal of Clinical Gastroenterology, 41
J. Llovet, J. Bustamante, A. Castells, R. Vilana, M. Ayuso, M. Sala, C. Brú, J. Rodés, J. Bruix (1999)
Natural history of untreated nonsurgical hepatocellular carcinoma: Rationale for the design and evaluation of therapeutic trialsHepatology, 29
Hyo‐suk Lee, Joo-Sung Kim, I. Choi, J. Chung, Jae Park, C. Kim (1997)
The safety and efficacy of transcatheter arterial chemoembolization in the treatment of patients with hepatocellular carcinoma and main portal vein obstructionCancer, 79
Zaibo Jiang, H. Shan, Xin-Ying Shen, Mingsheng Huang, Zheng-ran Li, K. Zhu, S. Guan (2004)
Transjugular intrahepatic portosystemic shunt for palliative treatment of portal hypertension secondary to portal vein tumor thrombosis.World journal of gastroenterology, 10 13
W. Chung, B. Jang, K. Park, K. Cho, J. Hwang, Sung Ahn, Yong Kim, Young Kim, Yong Kim (2005)
[Effect of transjugular intrahepatic portosystemic shunt for variceal bleeding in hepatocellular carcinoma patients with portal vein thrombosis].The Korean journal of hepatology, 11 2
Lei Liu, Yan Zhao, X. Qi, Guohong Cai, Chuang-ye He, Wengang Guo, Z. Yin, Hui Chen, Xi Chen, D. Fan, G. Han (2014)
Transjugular intrahepatic portosystemic shunt for symptomatic portal hypertension in hepatocellular carcinoma with portal vein tumor thrombosisHepatology Research, 44
JA Burger, A Ochs, K Wirth (1997)
The transjugular stent implantation for the treatment of malignant portal and hepatic vein obstruction in cancer patientsAnn Ocol, 8
Jian-Bo Zhao, Chao Feng, Qiaohua Zhu, Xiao-feng He, Yan-hao Li, Yong Chen (2014)
Transjugular intrahepatic portosystemic shunt with covered stents for hepatocellular carcinoma with portal vein tumor thrombosis.World journal of gastroenterology, 20 6
R. Dhanasekaran, J. West, P. Gonzales, R. Subramanian, S. Parekh, J. Spivey, Louis Martin, Hyun Kim (2010)
Transjugular Intrahepatic Portosystemic Shunt for Symptomatic Refractory Hepatic Hydrothorax in Patients With CirrhosisThe American Journal of Gastroenterology, 105
HS Lee, JS Kim, IJ Choi (1997)
The safety and efficacy of transcatheter arterial chemoembolization in the treatment of patients with hepatocellular carcinoma and main portal vein obstruction: a prospective controlled studyCancer Am Cancer Soc, 79
EA Tsochatzis, J Bosch, AK Burroughs (2014)
Liver cirrhosisLancet, 383
M. Wallace, D. Madoff, K. Ahrar, C. Warneke (2004)
Transjugular intrahepatic portosystemic shunts: Experience in the oncology settingCancer, 101
J. Burger, A. Ochs, K. Wirth, D. Berger, R. Mertelsmann, R. Engelhardt, M. Roessle, K. Haag (1997)
The transjugular stent implantation for the treatment of malignant portal and hepatic vein obstruction in cancer patients.Annals of oncology : official journal of the European Society for Medical Oncology, 8 2
Cardiovasc Intervent Radiol (2017) 40:1372–1382 DOI 10.1007/s00270-017-1655-8 CLINICAL INVESTIGATION VENOUS INTERVENTIONS Transjugular Intrahepatic Portosystemic Shunt for Portal Hypertension in Hepatocellular Carcinoma with Portal Vein Tumor Thrombus 1,4 2 3 1 • • • Bin Qiu Kai Li Xiaoqun Dong Fu-Quan Liu Received: 10 December 2016 / Accepted: 18 April 2017 / Published online: 9 May 2017 Springer Science+Business Media New York and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2017 Abstract The symptoms of portal hypertension were well relieved. Purpose In patients with hepatocellular carcinoma (HCC), Variceal bleeding was successfully controlled and termi- limited therapeutic options are available for portal hyper- nated in 100% of patients, with a recurrence rate of 39.2% tension resulted from portal vein tumor thrombus (PVTT). in 12 months. Refractory ascites/hydrothorax was con- We aimed to determine safety and efficacy of TIPS for trolled partially or completely in 92.9% of patients during treatment of symptomatic portal hypertension in HCC with 1 month after TIPS, with a recurrence rate of 17.9% in PVTT. 12 months. Survival rate at 6, 12, 24, and 36 months was Methods We evaluated clinical characteristics of 95 75.8, 52.7, 26.4, and 3.3%, respectively. No unexpected patients with HCC and
CardioVascular and Interventional Radiology – Springer Journals
Published: May 9, 2017
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.